More on COYA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-94.4% Growth)
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (8/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Coya Therapeutics (NQ:COYA)
Delayed: 4.92 -0.11 (2.19%)
Prev. Close $5.03  
Open$5.09 
52 Wk High$ 
52 Wk Low$ 
Day High$5.13 
Day Low$4.81 
P/E N/A  
EPS$ 
Volume215,714 

Friends, Peers and Foes (?): AVIR, ABBV, CARM, LLY, MEIP (more...)

Jun 18, 2026 08:00 AM Coya Therapeutics to Present ALSTARS Trial Design at the ENCALS 2026 Meeting
Jun 15, 2026 08:00 AM Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease
Jun 8, 2026 08:00 AM Coya Therapeutics begins extension phase of ALS drug trial
Jun 8, 2026 08:00 AM Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase
Jun 5, 2026 02:13 AM Roth/MKM Starts Coya Therapeutics (COYA) at Buy
May 27, 2026 08:00 AM Coya Therapeutics to Present ALSTARS Trial Design at the 5th ALS Drug Development Summit
May 13, 2026 08:34 AM Form ARS Coya Therapeutics, Inc. For: Dec 31
May 13, 2026 08:32 AM Form DEFA14A Coya Therapeutics, Inc.
May 13, 2026 08:30 AM Form DEF 14A Coya Therapeutics, Inc. For: Jun 25
May 12, 2026 08:59 AM Coya Therapeutics, Inc. (COYA) Tops Q1 EPS by 37c
View All Articles

Entities mentioned with COYA

View All Entities